Presenting a preclinical and translational evaluation of a bispecific antibody–drug conjugate in advanced prostate cancer: doi.org/10.1172/JCI2...
Yao Zhu & team report on a targeted therapy against EGFR & HER3 that delivers a cytotoxic payload and demonstrates effectiveness in mCRPC.
